EGCG is produced in PharmBioTec under GMP (§14 AMG) conditions (content >97%).
The testing of EGCG is carried out in the quality control department of PharmBioTec GmbH, where regular quality inspections of pharmaceutical raw materials and finished drugs are carried out at the highest level.
Each batch of EGCG is produced according to established and validated manufacturing instructions, analytical methods and drug legal requirements and is checked for purity and content. Only the most modern, regularly maintained and qualified, state-of-the-art equipment is used to manufacture and test the products, in order to ensure the reliability of the data collected. The highly qualified employees are continuously trained by internal and external courses and further education. Regular GMP inspections certify that PharmBioTec GmbH complies with the GMP guidelines.
Regular quality control ensures that only EGCG that meets the highest quality standards is released. Thus EGCG is suitable as an active ingredient for all imaginable places of application; from topical, oral to parenteral - EGCG is available for a variety of therapeutic options.